Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
507894
Reference Type
Journal Article
Title
Kynurenine pathway metabolism in human blood-brain-barrier cells: implications for immune tolerance & neurotoxicity
Author(s)
Owe-Young, R; Webster, NL; Mukhtar, M; Pomerantz, RJ; Smythe, G; Walker, D; Armati, PJ; Crowe, SM; Brew, BJ
Year
2008
Is Peer Reviewed?
Yes
Journal
Journal of Neurochemistry
ISSN:
0022-3042
EISSN:
1471-4159
Volume
105
Issue
4
Page Numbers
1346-1357
Language
English
DOI
10.1111/j.1471-4159.2008.05241.x
Abstract
The catabolic pathway of L-tryptophan (L-trp), known as the kynurenine pathway (KP), has been implicated in the pathogenesis of a wide range of brain diseases through its ability to lead to immune tolerance and neurotoxicity. As endothelial cells (ECs) and pericytes of the blood-brain-barrier (BBB) are among the first brain-associated cells that a blood-borne pathogen would encounter, we sought to determine their expression of the KP. Using RT-PCR and HPLC/GC-MS, we show that BBB ECs and pericytes constitutively express components of the KP. BBB ECs constitutively synthesized kynurenic acid, and after immune activation, kynurenine (KYN), which is secreted basolaterally. BBB pericytes produced small amounts of picolinic acid and after immune activation, KYN. These results have significant implications for the pathogenesis of inflammatory brain diseases in general, particularly human immunodeficiency virus (HIV)-related brain disease. Kynurenine pathway activation at the BBB results in local immune tolerance and neurotoxicity: the basolateral secretion of excess KYN can be further metabolized by perivascular macrophages and microglia with synthesis of quinolinic acid. The results point to a mechanism whereby a systemic inflammatory signal can be transduced across an intact BBB to cause local neurotoxicity.
Keywords
blood-brain barrier; IDO; immune tolerance; neurotoxicity; quinolinic; acid; tryptophan metabolism; microvascular endothelial-cells; indoleamine 2,3-dioxygenase activity; mycobacterium-avium complex; quinolinic acid; picolinic-acid; t-cell; interferon-gamma; 3-hydroxyanthranilic acid; cerebrospinal-fluid; dendritic cells
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity